CFS
TTRX

Cannon Financial Strategists’s Turn Therapeutics TTRX Stock Holding History

Cannon Financial Strategists’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73K Buy
+10,000
New +$46.5K 0.01% 132

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cannon Financial Strategists's TTRX Position: Q2 2026 in Review

Cannon Financial Strategists opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 10,000 shares worth $73K. The stake represents 0.01% of the portfolio and ranks #132 among its holdings.

14 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Cannon Financial Strategists held 10,000 shares of Turn Therapeutics worth $73K as of Q2 2026.
  • Turn Therapeutics was a new Cannon Financial Strategists position in Q2 2026.
  • Turn Therapeutics made up 0.01% of Cannon Financial Strategists's portfolio in Q2 2026, its #132 holding.
  • 14 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Cannon Financial Strategists's 13F filing for Q2 2026, filed 7 Aug 2026.